An observational study in Cognitive Impairment, Emergency Care and Dementia, sponsored by Yale University. Completed at 2 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-03-07.
Sponsored by Yale University · Observational
This is an observational study of the pragmatic implementation of an ED screening, outpatient referral, and care coordination process for older ED patients who may have UCID.
Embedded pragmatic, implementation pilot that incorporates training, ED assessment for delirium and dementia risk, referral of ED patients with undiagnosed cognitive impairment and dementia for primary care feedback and care recommendations. This pilot would gather observational data evaluating the feasibility of incorporating cognitive impairment screens into routine ED delirium assessments, and developing optimal work flow for identifying and referring ED patients with suspected (undiagnosed) dementia for confirmatory evaluation and care coordination.
2,172 studies on the registry are indexed under Dementia; 541 are open to participants now.
This study's enrollment of 100 is below the median of 250 across 482 observational studies indexed under Dementia.
Browse Dementia studies →Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.
Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
All community dwelling ED patients 65 years of age or older seen in the Yale New Haven Health System (YNHHS) St. Raphael's Campus (SRC) ED or Northwestern Memorial Hospital (NMH) ED.
Exclusion Criteria:
Routine ED screening for delirium and memory problems with referral for outpatient assessment of cognitive impairment.
Diagnostic Test: PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
1. ED assessment for suspected dementia. 2. positive ED patients referred for outpatient clinic cognitive impairment assessment. 3. positive clinic patients referred to primary care with brain health patient plan.
Percentage of Patients With Confirmed Delirium or Dementia
percentage of patients discharged from ED positive for delirium or dementia among total number of patients 65+
Time frame: 1 year
Rates of Outpatient Assessment Referral of Patients With Suspected Dementia
number of patients with appointment to Alzheimer's Dementia Centers or geriatrics outpatient clinic / number of patients given information sheet or referred to outpatient clinic
Time frame: 30 days
Number of Participants Diagnosed With Dementia Among Those With Completed Outpatient Assessment
number of patients diagnosed with dementia (all categories) among those that completed the outpatient assessment
Time frame: Up to 100 days from ED discharge
Rates of Connection With Primary Care
number of patients with PCP follow-up about brain health plan of the number of patients with outpatient confirmation of Dementia or MCI
Time frame: 30 days
| Milestone | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Started | 100 |
| Completed | 100 |
| Not completed | 0 |
percentage of patients discharged from ED positive for delirium or dementia among total number of patients 65+
| percentage of participants | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Percentage of Patients With Confirmed Delirium or Dementia | 30.8 |
number of patients with appointment to Alzheimer's Dementia Centers or geriatrics outpatient clinic / number of patients given information sheet or referred to outpatient clinic
| Participants | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Rates of Outpatient Assessment Referral of Patients With Suspected Dementia | 26 |
number of patients diagnosed with dementia (all categories) among those that completed the outpatient assessment
| Participants | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Number of Participants Diagnosed With Dementia Among Those With Completed Outpatient Assessment | 15 |
number of patients with PCP follow-up about brain health plan of the number of patients with outpatient confirmation of Dementia or MCI
| Participants | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Rates of Connection With Primary Care | 19 |
Collected over Adverse events (AEs) evaluated retrospectively via chart review during 90-day of follow-up period.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ED Delirium & Dementia Screening & Outpatient Referral | 2/100 (2%) | 0/100 (0%) | 6/100 (6%) |
| Event | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Mood alterationPsychiatric disorders | 3/100 |
| Mood alterationPsychiatric disorders | 3/100 |
| Age, Continuous(years) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Mean | 82 ± 7.8 |
| Sex: Female, Male(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Female | 63 |
| Male | 37 |
| Ethnicity (NIH/OMB)(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Hispanic or Latino | 9 |
| Not Hispanic or Latino | 91 |
| Unknown or Not Reported | 0 |
| Race/Ethnicity, Customized(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Black or African American | 29 |
| White | 60 |
| Asian | 5 |
| Other | 1 |
| Unknown or not reported | 5 |
| Region of Enrollment(participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| United States | 100 |
| ED delirium diagnosis(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Count of participants | 9 |
| ED Confusion Assessment Method (CAM) Positive(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| Count of participants | 7 |
| Chronic Conditions(Participants) | ED Delirium & Dementia Screening & Outpatient Referral |
|---|---|
| High blood pressure | 73 |
| Stroke | 14 |
| TBI | 2 |
| PVD | 4 |
| Renal failure | 14 |
| Diabetes | 33 |
5 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yale University